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Background: The possible role of secretory products of fibrous tissue in the development of hepatocellular
carcinoma (HCC) complicating chronic hepatitis C was investigated. Our hypothesis was that gremlin, secreted by
fibroblasts, inhibited bone morphogenic protein (BMP), which mediates stem cell maturation into adult functioning
hepatocytes, and thus, arrest stem cell maturation and promoted their proliferation in an immature state possibly
culminating into development of HCCs.
Results: Protein expression of cytokeratin 19 (CK19) and fibroblast growth factor 2 (FGF-2), and mRNA expression of
gremlin and BMP-7 were studied in 35 cases of chronic hepatitis, cirrhosis and HCC complicating chronic hepatitis
C. CK19 expression was higher in cases of cirrhosis (0.004), which correlated with the grade (r = 0.64, p = 0.009)
and stage (r = 0.71, p = 0.001). All HCCs were negative for CK19. Stem cell niche activation (as indicated as a ductular
reaction) was highest in cases of cirrhosis (p = 0.001) and correlated with CK19 expression (r = 0.42, p = 0.012),
the grade(r = 0.56, p = 0.024) and stage (0.66, p = 0.006). FGF-2 expression was highest in HCCs and correlated with
the grade (r = 0.6, p = 0.013), stage (0.72, p = 0.002), CK19 expression (r = 0.71, p = 002) and ductular reaction
(0.68, p = 0.004) in hepatitis cases. Higher numbers of cirrhosis cases and HCCs (p = 0.009) showed gremlin
expression, which correlated with the stage (r = 0.7, p = 0.002). Gremlin expression correlated with that of CK19
(r = 0.699, p = 0.003) and FGF2 (r = 0.75, p = 0.001) in hepatitis cases.
Conclusions: Fibrosis promotes carcinogenesis by fibroblast-secreted gremlin that blocks BMP function and
promotes stem cell activation and proliferation as well as possibly HCC development.
Keywords: Gremlin, Bone morphogenetic protein 7, Hepatocellular carcinoma, Hepatic progenitor cellsBackground
The variability in the prognosis of individuals with hepa-
tocellular carcinoma (HCC) suggests that HCC may
comprise several distinct biological phenotypes. These
phenotypes may result from activation of different onco-
genic pathways during tumorigenesis and/or a different
cell of origin [1]. Enhanced proliferation and maturation
arrest of hepatic progenitor/stem cells have been consid-
ered the origin of HCCs [1]. However, the link between* Correspondence: nahedbaddour@yahoo.com
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reproduction in any medium, provided the orcirrhosis and stem cell proliferation has not been fully
elucidated. This link is multifaceted and complex with
interplay of multiple factors that enhance or inhibit the
proliferative rate of hepatic progenitor/stem cells, which
culminates in HCC development. The outcome depends
on the balance between stimulatory and regulatory sig-
nals that reach these stem cells [2,3]. The fate of hepatic
progenitor/stem cells is determined by various growth
factors, some of which are promoters of stem cell differ-
entiation, and their exit from the stem cell niche as bone
morphogenic proteins (BMPs), whereas other growth
factors, such as basic fibroblast growth factor (b- FGF)
and activin/nodal (the other arm of action of Transform-
ing growth factor β (TGF-β) maintain their stemnessLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Scores of ductular reactions among groups
Marker Hepatitis Cirrhosis HCC
(n=35) (n=35) (n=35)
Ductular reaction n(%) n(%)
0 7(18%) 0(0.0%) NA MCp 0.001
1 19(56%) 0(0.0%) NA
2 7(18%) 8(22.9%) NA
3 2(6%) 27(77.1%) NA
NA not assayed.
MCp p value for the Monte Carlo test.
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BMP-7 mediates sprouting of the liver bud from the
central foregut endoderm, which is essential for hepato-
cytic differentiation [4]. BMP-7 protein has been found
in inflamed fibrotic livers [5] and its mRNA has been
detected in stellate and Kupffer cells of the adult liver
[6]. Several proteins antagonize BMP signaling, such as
follistatin, noggin and members of the DAN family in-
cluding cerberus and gremlin [7]. Gremlin is a protein
secreted by fibroblasts and its mRNA is highly expressed
under fibrotic conditions such as advanced diabetic
nephropathy [8].
In this study, we presumed that gremlin, secreted by
hepatic myofibroblasts in cases of fibrosis (cirrhosis),
would antagonize the effects of BMP on stem cell differ-
entiation and its anti-fibrogenic property. Antagonism of
BMP-7 may arrest stem cell maturation and promote
proliferation in an immature state, thereby possibly cul-
minating in HCC development.
We investigated the role of cirrhosis and FGF-2 in the
pathogenesis of HCC development complicating chronic
HCV by detection of gremlin and BMP-7 mRNA and
correlating their presence with hepatic progenitor cell
numbers in cases of cirrhosis and HCC complicating
chronic HCV in Egyptian patients with HCV type 4.Results
Patient ages ranged from 23 to 52 (mean ± standard devi-
ation (SD) 36± 8.7), and 39 to 70 (mean± SD 53.67 ± 7.4)
for hepatitis, and cirrhosis and HCC cases, respectively
(cirrhosis and HCC cases were obtained from the same
segmentectomy specimens).Histopathological studies
Grades of the hepatitis group ranged from 1 to 7
(mean ± SD 2.93 ± 1.6), in which none were grade 0,
seven (18.8%) each were grades 1 or 2, 13 (37.5%)
were grade 3, two (6.3%) were grade 4, four (12.5%)
were grade 5, none were grade 6, and two (6.3%) were
grade 7 (Additional file 1: Table S1). While those of
the cirrhosis group ranged from 1 to 8 (mean ± SD
4.3 ± 2.5), in which six (17%) were grade 1, two (6.7%)
were grade 2, four (13.3%) were grade 3, eight (22%)
were grade 4, none were grade 5, and five (14%) each
were grades 6, 7 or 8 (Additional file 1: Table S1).
Edmondson’s grades of HCCs were three cases of
grade 1, 14 cases of grade 2, nine cases of grade 3 and
nine cases of grade 4. While no differences were
observed between the histological grades of hepatitis
and cirrhosis cases (p = 0.09), significant differences in
the ductular reaction (p = 0.001) were observed be-
tween these two groups (Table 1). The ductular reac-
tion (Additional file 2: Figure S1) correlated with thegrade (r = 0.56, p = 0.024) and stage (0.66, p = 0.006) in
hepatitis cases.
Immunohistochemical results
Positive staining of CK19 in cell membranes was
observed in both hepatitis and cirrhosis groups. Positiv-
ity was observed in and around portal tracts and along
the fibrous septa with few intra-acinar positive cells
(Figure 1a, b and c). Values were in the range of 0–10 (×
2.63 ± 2.7) and 0–90 (× 18 ± 23.48) for hepatitis and cir-
rhosis cases, respectively. Cirrhosis cases (Figure 1b)
showed higher levels of positivity (p = 0.004) than hepa-
titis cases (Figure 1a). All HCC cases (Figure 1c) were
negative for CK19 (Table 2).
Among hepatitis cases, positive correlations were
observed between each of CK19 expression and each
grade (Figure 1d) and stage (Figure 1e) (r = 0.63, p = 0.009
and r = 0.56, p = 0.025, respectively). Correlation with the
stage was not found in cirrhosis cases (fixed stage 6
Hepatitis activity index (HAI) by definition). However,
correlation with the grade was detected (r = 0.753,
p = 0.001). Ductular reactions correlated with CK19 ex-
pression in hepatitis cases (r = 0.42, p = 0.012) (Figure 1f ).
Hepatitis and cirrhosis groups showed positive FGF-2
expression as granular cytoplasmic staining in periportal
(Figure 2a), perivenular (Figure 2b) and intermediate
(Figure 2c) hepatocytes as well as bile ductular epithelial
cells. In HCCs, malignant hepatocytes also expressed
FGF-2 (Figure 2d). FGF-2 positivity was higher in HCCs
than in hepatitic and cirrhotic tissues, but was not
significant (Table 3).
FGF-2 correlated with each of grade (r =0.603, p=0.013)
(Figure 3a, Table 4), stage (r = 0.721, p=0.002) (Figure 3b,
Table 4) and ductular reaction (r =0.684, p=0.004)
(Figure 3c, Table 4) in hepatitis cases. In hepatitis and cir-
rhosis cases, positive correlations were detected between
FGF-2 and CK19 positivity (r =0.703, p=0.002 (Figure 3d)
and r=0.536, p=0.048, respectively) (Table 4).
Gremlin expression and its correlations
Gremlin mRNA (198 bp) was expressed in 24/35 (68.7%)






Figure 1 Cases of hepatitis, cirrhosis and HCC stained for CK19. A case of chronic hepatitis showing (a) single scattered CK19-positive cells
in the lobule (arrow) (×100). (b) A case of cirrhosis showing a higher grade of CK19-positive ductular reaction and individual positive cells in the
lobule (arrow). (CK19, ×100). (c) A case of HCC showing negativity for CK19 in tumor cells. (Streptavidin-peroxidase technique, anti-CK19
monoclonal antibody, ×200). In right panels: Line graphs show significant correlations between CK19 and each (d) grade, (e) stage and
(f) ductular reaction.
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(Table 5, Figure 4d). Gremlin mRNA levels were higher
in HCCs and cirrhosis cases than in hepatitis cases
(p = 0.009) (Table 5, Figure 4d).
In hepatitis cases, gremlin expression correlated with
the stage (r = 0.699, p = 0.003) (Figure 4e) and CK19positivity (r = 0.223, p = 0.04) (Table 6), but not with the
stage in the cirrhosis group due to the fixed stage (stage
6 HAI by definition). Gremlin expression did not correl-
ate with the number of FGF-2 positive cells (r = 0.548,
p = 0.191) or BMP-7 mRNA level (r = 0.051, p = 0.851) in
the hepatitis group. However, it did positively correlate
Table 2 CK19 positivity among groups
CK 19 Hepatitis Cirrhosis HCC
(n=35) (n=35) (n=35)
Range 0.0 – 10.0 0.0 – 90.0 0.0 – 0.0
Mean ± SD 2.63 ± 2.70 18.0 ± 23.48 0.0 ± 0.0
Median 2.0 9.0 0.0
Z1 (p) 2.866
* (0.004) 4.305* (<0.001)
Z2 (p) 4.665
* (<0.001)
Z1 Z for the Mann–Whitney test between hepatitis and other groups.
Z2 Z for the Mann–Whitney test between cirrhosis and HCC groups.
*Statistically significant.
Table 3 Level of FGF-2 positivity among groups
FGF 2 Hepatitis Cirrhosis HCC
(n=35) (n=35) (n=35)
Range 0.060.0 – 16.0.0 0. 0.0 – 16.00 – 16.0 0.0 – 70.0
Mean ± SD 5.06 ± 4.30± 4.30 6.13 ± 5.0.0 14.67 ± 18.67
Median 4.544.50 4.04.0 9.0
Z1 (p) .50.557(0.578) 1.308 (0.191)
Z2 (P) 0.937 (0.349)
Z1 Z for the Mann–Whitney test between HCV and other groups.
Z2 Z for Mann Whitney test between cirrhosis and HCC.
* Statistically significant at p ≤ 0.05.
Guimei et al. BMC Research Notes 2012, 5:390 Page 4 of 10
http://www.biomedcentral.com/1756-0500/5/390with BMP-7 levels in the cirrhosis group (r = 0.602,
p = 0.023) (Table 6).
BMP-7 expression and its correlations
No significant differences in the level of BMP-7 mRNA
expression between the three study groups were
detected (Figure 5a–d and i, Table 5). However, BMP-7
mRNA correlated significantly with the levels of ductular
reactions (r = 0.576, p = 0.031) in the cirrhosis group
(Figure 5ii) (Table 7).
Discussion
The current study aimed to identify a possible link be-
tween fibrosis/cirrhosis and HCC development in
chronic HCV type 4 cases. Under normal conditions,
FGFs, acting via BMP-7, stimulate maturation of stem
cells into functional mature hepatocytes or cholangio-
cytes. However, under fibrotic conditions, gremlin is
produced by fibrotic tissue [7,8] and inhibits BMPa
c
Figure 2 Cases of hepatitis, cirrhosis and HCC stained for FGF-2. A cas
periportal areas (×200), (b) the pericentral zone (×400) and (c) intermediate
HCC tumor cells (×200). (streptavidin-peroxidase technique, anti-FGF2 monfunction [7,8]. This production of gremlin may cause
maturation arrest of stem cells and their proliferation in
an immature state predisposes HCC development.
We found that CK19 was expressed at higher levels in
cirrhosis cases, compared with those of hepatitis cases.
CK19 expression correlated with the grade and stage of
the disease. These findings are consistent with data from
Ravazoula et al [9] and Libbrecht et al [10]. The correl-
ation between stem cell niche activation, manifested as
significantly increased ductular reactions [11], and
increased severity (grade/stage/fibrosis) of the disease,
which were observed in the present study, confirms the
notion that damage of the epithelial compartment of the
liver by chronic disease causes replicative senescence of
hepatocytes, which leads to reserve cell compartment ac-
tivation [12]. Several studies using detailed immunophe-
notyping of HCCs show that a substantial number of
HCCs (28–50%) express progenitor cell markers includ-
ing CK7, CK19 and OV6 [13-15]. In the present study,d
b
e of chronic hepatitis showing a few positive hepatocytes in (a)





Figure 3 Line graphs of correlations between FGF-2 positivity and each (a) grade, (b) stage, (c) ductular reaction and (d) CK19
positivity.
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cells were observed in cirrhosis cases, HCCs did not
show CK19 positivity. This observation can be inter-
preted in two ways: first, expression of immune markers
by stem cells is stage-specific and not lineage-specific
[16]; and CK19 represents an early marker of stem cells,which is normally expressed in hepatoblasts [17]. In
HCCs and chronic HCV type 4 cases, stem cells are
probably at a different stage of maturation/differenti-
ation than that required to express this particular mar-
ker. Alternatively, the negativity of our HCC cases for
CK19 may be attributed to the clinical setting in which
Table 4 Correlations between FGF-2 and other
parameters among groups
FGF-2 Grade Stage Ductular reaction CK19
HCV r 0.603* 0.721* 0.684* 0.703*
patients p 0.013 0.002 0.004 0.002
Cirrhotic r 0.446 0.388 0.483 0.536*
patients p 0.096 0.153 0.080 0.048
Rho spearman’s correlation coefficient.
*p < 0.05.
Table 5 Levels of positivity for gremlin and BMP-7 among
groups
Positive cases (%) Hepatitis Cirrhosis HCC MCp
n (%) n (%) n (%)
Gremlin mRNA 24 (68.7%) 35 (100%) 35 (100%) 0.009*
BMP 7 mRNA 16 (43.8%) 27 (78.6%) 25 (73.3%) 0.115
n actual numbers of positive cases.
MCp p value for the Monte Carlo test.
*Statistically significant at p ≤ 0.05.
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formed using experimental models of carcinogenesis
[18], or a different disease setting (etiologic factors other
than HCV type 4) such as the studies by Durnez et al
[15], Lyer et al [18] and others [16] where the etiology of
liver disease was quite heterogeneous with only very few
cases resulting from HCV infection. Our study was con-
ducted exclusively with HCV type 4 induced HCCs; the
main predisposing factor of HCC in Egypt [19]. The
pathogenetic pathways activated in HCCs complicating
HCV may be quite different from those occurring in1 2 3
1        2          3   4         5          6        7  





Figure 4 Gremlin expression among the three study groups. (a) Grem
2, 3, 4 and 5. PCR products are not observed in lane 1. A 25 bp size marker
Note: all cases show a positive band at 198 bp. Lane 6 is a 25 bp marker (c
is a 25 bp marker (Capillary electrophoresis using e-gene, HAD-GT12). (d) L
correlation between the stage and gremlin expression.other settings such as chemical carcinogenesis. In fact,
even chemical carcinogenic regimens result in activation
of different pathways. Lingala et al [20] show similar
results using a different set of stem cell markers (CD44,
CD90 and CD133) with few HCCs showing very limited
expression of these markers, although they were found
in cases of chronic HCV and dysplastic foci. Dunsford et
al [21] used monoclonal antibodies to study sequential
histopathologic changes that occurred during two regi-
mens of chemical carcinogenesis in the rat. The Solt-
Farber regimen caused prominent oval cell proliferation4 5 6 
       8        9         10       11 




lin mRNA expression in HCV cases. PCR products are observed in lanes
was used in lane 6. Note: additional bands. (b) cirrhosis specimens.
) In HCC specimens, all cases show a positive band at 198 bp. Lane 6
evel of gremlin positivity among study groups. (e) Significant
Table 6 Correlations between gremlin mRNA expression
and studied markers in hepatitis and cirrhosis groups
Gremlin Grade Stage Ductular reaction CK 19 BMP 7
HCV r 0.136 0.699* 0.276 0.223 0.051
p 0.615 0.003 0.301 0.04 0.851
Cirrhosis
r 0.526 0.994 0.602
p 0.044 NP 0.001 NP 0.023
Rho (r) Spearman coefficient *Statistically significant at p ≤ 0.05.
NP Not performed because gremlin was expressed in 100% of cases and all 35
cases of this group received a score of 3 for CK19 positivity. Therefore, a
correlation was not feasible.
Note: a correlation was not performed with the stage (fixed stage 6 by
definition).
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administration of diethylnitrosamine produced minimal
oval cell proliferation and a few small nodules. These results
demonstrate that different etiologies lead to HCC develop-
ment via different pathogenetic pathways. Is it possible that
different cancer stem cells are activated by different patho-
genetic pathways, which results in a tumor (HCC) that is
actually not a single entity, but biologically different tumors
with a common morphology [22,23].
Gremlin antagonizes BMP function under several dis-
ease conditions including idiopathic pulmonary fibrosis
[24], proliferative vitreoretinopathy [25] and renal fibro-
sis [26]. It non-covalently binds to BMP family members
to prevent interactions with their cognate receptors, thus
altering the effective concentration of active signalling
molecule [27]. There are also claims that gremlin pos-
sesses an oncogenic role. Data from Namkoong et al
[28] and Sneddon et al [29] have shown that gremlin is
over-expressed in various human malignancies including
carcinomas of the cervix, lung, ovary, kidney, breast,
colon and pancreas as well as sarcomas. The source of
gremlin in highly cellular HCCs is Kupffer cells [30]. In
the present study, all three groups of patients expressed
gremlin mRNA that was significantly higher in cirrhosis
cases than hepatitis cases. Furthermore, gremlin mRNA
significantly correlated with the stage. This finding may
support the theory that fibroblast-secreted gremlin
blocks BMP-mediated stem cell maturation [31], with
possible HCC development in cirrhosis patients.
We detected FGF-2 expression in all study groups,
with a significant correlation noted between FGF-2 posi-
tivity and each grade and stage. FGF-2 is considered as
an autocrine repair hormone secreted following injury to
promote healing (fibrosis) [32,33] and neoangiogenesis
[34]. In our study, the distribution pattern of FGF-2
positivity in hepatitis cases is consistent with data from
Xiaodong et al [35] who recently elucidated the
localization of FGF-2 mRNA in these same regions in a
mouse fibrotic liver model [35]. Furthermore, FGF-2expression significantly correlated with CK19 expression,
implying that promotion of fibrogenesis by FGF [36]
leads to increased gremlin expression that blocks BMP-
7-mediated stem cell differentiation, which leads to pro-
liferation in an immature state, as shown by higher
CK19 positivity. This explanation is further supported by
our finding of a positive correlation between gremlin
mRNA expression, FGF-2 and CK19 positivity in the
hepatitis group. Thus, FGF-2 may have an oncogenic
role in HCC development.
Conclusions
Gremlin participates in the pathogenesis of HCC com-
plicating chronic hepatitis C type 4-related cirrhosis by
antagonizing the maturation inducing function of BMP-
7 rather than the actual production of BMP-7 in cir-
rhotic livers. This occurrence promotes the proliferation




The present study was conducted using 35 liver core bi-
opsies from patients with hepatitis (HCV type 4, shown
as positive by PCR) and 35 freshly collected segmentect-
omy specimens from patients with HCC complicating
HCV-related cirrhosis (segmentectomy specimens were
the source for both cirrhotic and carcinoma tissues).
Liver core biopsies were clinically indicated as a part of
the treatment strategy for chronic HCV infection (base-
line biopsy for grading and staging before combinatorial
treatment with Interferon alpha 2 B (IFN-α2b) and riba-
virin). The protocol of this study was approved by the
Ethics committee of the Faculty of Medicine, University
of Alexandria. Informed consent was obtained from
patients for use of these specimens for research
purposes.
Paraffin blocks of liver biopsies were obtained from the
archives of the Pathology Department at the Alexandria
Faculty of Medicine. Patients were selected sequentially
from our archives for hepatitis cases and cases sequentially
obtained from the clinic for cirrhosis and HCC cases
(paired specimens). All HCC cases were complicating
HCV type 4-related cirrhosis. Inclusion criteria were HCV
type 4 (as shown by PCR using Inno-LiPA I and II)
patients, and exclusion criteria included anti- hepatitis B
virus surface antibody HBV positivity, obesity, history of
alcoholism and diabetes mellitus.
Histopathologic study
Hematoxylin-eosin sections were examined to determine
the grade and stage of the hepatitis and cirrhosis cases
[37], ductular reaction and HCC grade [38]. Scores were
the mean determinations. A ductular reaction, a sign of
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Figure 5 Gel electrophoreograms of BMP expression among study groups. (a) BMP-7 mRNA expression in liver tissue from patients with
chronic hepatitis C. BMP-7 expression is observed in lanes 1, 3, 4 and 5 at 163 bp, whereas no DNA bands are present in lane 2. Note the extra
higher band at 250 bp. Lane 6 is a 25 bp size marker. (b): BMP-7 mRNA expression in cirrhotic liver tissue. PCR products are observed at 163 bp in
lanes 1, 2, 3, 4 and 6. Lane 5 shows no PCR products. Lane 7 is a 25 bp size marker. (c): BMP-7 mRNA expression in cirrhotic liver tissue. PCR
products are observed in lanes 8, 9 and 10, but not in lane 11. Lane 7 contains the marker. (d): BMP-7 mRNA expression in HCC cases. PCR
products are observed in lanes 1, 7, 8, 9 and 10. No PCR products are observed in lanes 2, 3, 4 and 6. Lane 5 contains the marker. (Capillary
electrophoresis using e-gene, HAD-GT12). (i) Bar graph showing the numbers of cases expressing BMP-7 mRNA among study groups.
(ii) Correlations between BMP-7 mRNA expression and ductular reactions in the cirrhosis group.
Guimei et al. BMC Research Notes 2012, 5:390 Page 8 of 10
http://www.biomedcentral.com/1756-0500/5/390stem cell niche activation, was graded on a scale from 0
to 3, according to the number of points of origin in the
perimeter of portal tracts showing a ductular reaction, as
follows: 0, none; 1, two or less points; 2, two to four
points; and 3, > four points.Immunohistochemical staining
Antibodies against CK19 (1:100, clone A53-B/A2.26).Lab Vision Corporation, Fremont, CA, USA), a stem
cell marker, and FGF-2 (1:50, clone Ab16828; Abcam,
Cambridge, UK were used together with an Ultravision
LP detection System, (Thermo scientific, Lab vision,
catalog # TL-015HD, Fremont, CA) horse radish perox-
idase polymer (HRP) polymer and diaminobenzidine
(DAB) plus chromogen (Cat#: TL-015HD; Lab Vision
Corporation) according to the manufacturer’s instruc-
tions. Epitope retrieval was performed by boiling in 2%
Table 7 Correlations between BMP-7 mRNA levels and
studied markers among groups
BMP 7 Grade Stage Ductular reaction CK 19 FGF 2 Gremlin
HCV
r −0.311 0.217 0.076 0.264 0.136 0.051
p 0.241 0.418 0.780 0.324 0.608 0.851
Cirrhosis
r 0.284 0.134 0.576* 0.065 0.196 0.602*
p 0.326 0.635 0.031 0.825 0.501 0.023
Rho (r): Spearman coefficient.
*Statistically significant at p ≤ 0.05.
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for 15 min. Sections were incubated with antibodies
overnight at 4°C. Bile ducts served as internal positive
controls for CK19 and kidney tubules for FGF-2. A posi-
tive reaction was considered only if single cells (not
forming part of a ductular reaction) showed membrane
staining for CK19 and cytoplasmic staining for FGF-2.
Positive cells were counted in 10 random high power
fields (×400) for each case by two pathologists, separ-
ately. Results were presented as the mean ± SD of both
readings.RNA extraction and reverse transcription PCR analysis
Total RNA was extracted from fresh snap frozen liver tis-
sue using Trizol (Cat# 15596-026, Invitrogen; Madison,
WI, USA). The concentration and purity of extracted
RNA were determined using a nanodrop ND-1000 spec-
trophotometer. Samples were accepted when the A260/
A280 ratio (nucleic acid/protein absorbance) was ≥ 1.8.
Reverse transcription of extracted RNA was performed
using random hexamer primers and a Transcriptor First
Strand cDNA Synthesis kit (Cat#: 04 379 012 001; Roche
diagnostics, Switzerland) according to manufacturer’s
instructions. cDNA was either processed immediately or
stored at –20°C. cDNA amplification was performed with
a QB-96 thermal cycler using Atlas hotTaq (Lot#:
Js20080508; Bioatlas, Tartu, Estonia) under the following
conditions: 15 min at 95°C followed by 40 cycles of 45 s at
92°C, 30 s at 55°C and 90 s at 72°C. Primer sequences
were those described by Wordinger et al [39]. Gene detec-
tion was performed by e-gene capillary electrophoresis,
HAD-GT12 according to the manufacturer’s instructions.
The housekeeping gene, PBGD was used to confirm the
integrity of extracted RNA.
BMP-7; F: AGCCCGGGTAGCGCGTAGAG, R: GCG
CCGGTGGATGAAGCTCGA; gremlin (DRM); F: AT
CAACCGCTTCTGTTACGG, R: ATGCAACGACACT
GCTTCAC. (Cat#s. 10336-022; D4063F04, for BMP-7
and D4063F05, D4063F06, D4063F07, for DRM; Invitro-
gen, Madison, WI, USA).Statistical analyses
Statistical analyses were performed using SPSS 17 (SPSS
Inc., Chicago, IL, USA). Monte Carlo and Mann–Whitney
tests were used to calculate the significance of differences
between groups. Pearson and Spearman coefficients were
used to find correlations between study parameters
among patient groups.Additional files
Additional file 1: Table S1. Differences in the grade and stage among
groups.
Additional file 2: Figure S1. Ductular reactions among study groups.
Note in (a) a portal tract with a ductular reaction from three points in its
circumference (score of 2) (×200). (b) A case showing a ductular reaction
originating from four points in the circumference of the tract (score of 2).
(×400) (hematoxylin-eosin).
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